Detalhe da pesquisa
1.
Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model.
Allergy
; 76(4): 1041-1052, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869882
2.
An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents.
Pediatr Allergy Immunol
; 25(8): 760-6, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25378225
3.
Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study.
Adv Ther
; 37(6): 2932-2945, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342352
4.
Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions.
Diabetes Technol Ther
; 11(6): 379-83, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19459767
5.
Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data.
Expert Rev Clin Immunol
; 15(9): 921-928, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31403823
6.
The IRIS V study: pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions.
Diabetes Technol Ther
; 10(3): 206-12, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18473695
7.
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
Metabolism
; 56(4): 491-6, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17379006
8.
Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study.
Drugs Real World Outcomes
; 4(2): 109-117, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28540507
9.
Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study.
Adv Ther
; 34(6): 1382-1397, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28455783
10.
Optimum treatment strategies for polyallergic patients - analysis of a large observational trial.
Curr Med Res Opin
; 31(12): 2249-59, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26366617
11.
Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study.
Biomed Res Int
; 2015: 584291, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26351635
12.
Downregulation of the proinflammatory state of circulating mononuclear cells by short-term treatment with pioglitazone in patients with type 2 diabetes mellitus and coronary artery disease.
PPAR Res
; 2011: 647017, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21808640
13.
Increased prevalence of cardiovascular disease and risk biomarkers in patients with unknown type 2 diabetes visiting cardiology specialists: results from the DIASPORA study.
Diab Vasc Dis Res
; 7(2): 145-50, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20382778
14.
Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study.
Atherosclerosis
; 201(1): 155-62, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18374336
15.
Pioglitazone improves metabolic markers in patients with type 2 diabetes independently from physical activities: results from the IRIS III study.
J Diabetes Sci Technol
; 2(2): 244-9, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19885350
16.
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
J Am Coll Cardiol
; 49(3): 290-7, 2007 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-17239709